Drug Database
Back to search

Poland· PL-100483875

Dexmedetomidine Farmak

A dexmedetomidine product containing dexmedetomidinum, registered in Poland by Farmak International Sp. z o.o.. The same ATC class is registered in 17 of our 19 countries.

ATC N05CM18

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedDexmedetomidine FarmakATCN05CM18REGISTER NO.PL-100483875PACKS LISTED9CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about dexmedetomidinumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Dexmedetomidine is registered in 17 of 19 countries.

Countries holding a registration under ATC N05CM18 (dexmedetomidine), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 9 of them publish a price we can compare per daily dose
Search dexmedetomidine products by name

Dexmedetomidine · ATC N05CM18

17 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Dexmedetomidinum
Manufacturer
Farmak International Sp. z o.o.
Country
Poland (PL)
ATC code
N05CM18
ATC class
Dexmedetomidine
Defined daily dose
1 mg, P
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 9

  • gtin
    05907637916818
  • gtin
    05907637916825
  • gtin
    05907637916832
  • gtin
    05907637916849
  • gtin
    05907637916856
  • gtin
    05907637916863
  • gtin
    05907637916870
  • gtin
    05907637916887
  • gtin
    05907637916894

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

79 interactions on record for dexmedetomidine.

Graded by severity as the source publishes them — 60 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check dexmedetomidine against other medicinesHow interaction checks work

Dexmedetomidine · interactions on record

79 records

  • 60 moderate
  • 19 info

Most severe, free to view

  • PapaverineA03AD01moderate
  • DiphenhydraminA04AB05moderate
  • DronabinolA04AD10moderate
  • NabiloneA04AD11moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Dexmedetomidine in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All dexmedetomidine products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Dexmedetomidin Altan, Dexmedetomidin Altan Pharmaceuticals, S.A.
  • Belgium · Dexmedetomidine A.Forall, Dexmedetomidine Baxter
  • Bulgaria · Dexmedetomidine Ever Valinject, Dexmedetomidine Kalceks
  • Cyprus · Dexmedetomidine Baxter, Dexmedetomidine Ever Valinject
  • Czechia · Dexmedetomidine B. Braun, Dexmedetomidine Ever Pharma
  • Germany · Dexmedetomidin B. Braun, Dexmedetomidin Baxter
  • Denmark · Dexmedetomidin Kalceks, Dexmedetomidin Viatris
  • Estonia · Dexmedetomidine Auxilia, Dexmedetomidine Kabi
  • Spain · Dexmedetomidina Altan, Dexmedetomidina B. Braun
  • Finland · Dexmedetomidine B. Braun, Dexmedetomidine Baxter
  • France · Dexmedetomidine Altan, Dexmedetomidine Ever Pharma
  • United Kingdom (Northern Ireland) · Dexmedetomidine 100 Micrograms/Ml Concentrate For Solution For Infusion, Dexmedetomidine Altan Pharma
  • Greece · Dexmedetomidine /Kabi, Dexmedetomidine Ariti
  • Croatia · Deksmedetomidin Kabi, Deksmedetomidin Kalceks
  • Hungary · Dexmedetomidin Ever Pharma, Dexmedetomidine Kabi
  • Ireland · Dexmedetomidine As Kalceks, Dexmedetomidine B. Braun
  • Iceland · Dexdor, Dexmedetomidine Rph Pharma
  • Italy · Dexmedetomidina Galenica Senese, Dexmedetomidina Hikma
  • Liechtenstein · Dexdor
  • Lithuania · Dexmedetomidine Kabi, Dexmedetomidine Kalceks
  • Luxembourg · Dexmedetomidine Baxter, Dexmedetomidine Kabi
  • Latvia · Dexmedetomidine Kalceks, Dexmedetomidine Pharmidea
  • Malta · Dexmedetomidine Ever Valinject
  • Netherlands · Dexmedetomidine Altan Pharmaceuticals, S.A., Dexmedetomidine B. Braun
  • Norway · Dexdor, Dexmedetomidine B. Braun
  • Portugal · Dexmedetomidina A.Forall, Dexmedetomidina Acure
  • Romania · Dexmedetomidină Kabi, Dexmedetomidină Kalceks
  • Sweden · Dexmedetomidine B. Braun, Dexmedetomidine Baxter
  • Slovenia · Deksmedetomidin Kalceks, Deksmedetomidin Viatris
  • Slovakia · Dexmedetomidine B. Braun, Dexmedetomidine Ever Pharma

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/287800cc-ada8-4c4c-881f-905ebb515830
GET /v1/drugs/287800cc-ada8-4c4c-881f-905ebb515830?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Koncentrat do sporządzania roztworu do infuzji",
  "source": "urpl",
  "strength": "100 mcg/ml",
  "packaging": "05907637916818 ¦ Rpz ¦ 165317\n1 amp. 2 ml\n05907637916825 ¦ Rpz ¦ 165318\n25 amp. 2 ml\n05907637916832 ¦ Rpz ¦ 165319\n1 fiol. 2 ml\n05907637916849 ¦ Rpz ¦ 165320\n5 fiol. 2 ml\n05907637916856 ¦ Rpz ¦ 165321\n25 fiol. 2 ml\n05907637916863 ¦ Rpz ¦ 165322\n1 fiol. 4 ml\n05907637916870 ¦ Rpz ¦ 165323\n4 fiol. 4 ml\n05907637916887 ¦ Rpz ¦ 165324\n1 fiol. 10 ml\n05907637916894 ¦ Rpz ¦ 165325\n4 fiol. 10 ml",
  "substance": "Dexmedetomidini hydrochloridum 118 mcg/ml",
  "common_name": "Dexmedetomidinum",
  "pl_product_id": "100483875",
  "pozwolenie_nr": "29455",
  "auth_procedure": "DCP",
  "authorisation_validity": "2030-12-30"
}
API referenceMCP serverPlans

See everything about dexmedetomidine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console